| Jessica Redmond Hammond, | |
|
252 S 4th St, Lebanon, PA 17042-6111 | |
| (717) 270-7500 | |
| Not Available |
| Full Name | Jessica Redmond Hammond |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 252 S 4th St, Lebanon, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710366307 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 105301 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North American Partners In Anesthesia, Pennsylvania , Llc | 7517960834 | 368 |
| Orthopedic Assoc Of Lancaster Ltd | 8527041987 | 77 |
News Archive
Efforts focused on increasing the use of screening mammography among targeted groups of women should be made a top priority to achieve the largest reduction in late-stage breast cancers, according to the authors of a new study in the October 20 issue of the Journal of the National Cancer Institute.
Cytori Therapeutics, Inc. received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application that protects key therapeutic methods for its breast and soft tissue reconstruction products. This patent will protect Cytori's existing and future products when sold in the U.S.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre.
An intensive structured care program for hypertension management in primary care leads to some improvements in blood pressure control, results from the VIPER-BP trial show.
Getinge announces the next edition of the Intensive Care Unit (ICU) Experience which will take place in the Getinge Experience Center, Rastatt on Tuesday 19 September 2017. Over 50 customers from across Europe, Middle East & Africa will be in attendance and have the opportunity to network with scientific experts and medical device industry.
› Verified 6 days ago
| Entity Name | Lebanon Anesthesia Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407844079 PECOS PAC ID: 4688570997 Enrollment ID: O20031209000210 |
News Archive
Efforts focused on increasing the use of screening mammography among targeted groups of women should be made a top priority to achieve the largest reduction in late-stage breast cancers, according to the authors of a new study in the October 20 issue of the Journal of the National Cancer Institute.
Cytori Therapeutics, Inc. received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application that protects key therapeutic methods for its breast and soft tissue reconstruction products. This patent will protect Cytori's existing and future products when sold in the U.S.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre.
An intensive structured care program for hypertension management in primary care leads to some improvements in blood pressure control, results from the VIPER-BP trial show.
Getinge announces the next edition of the Intensive Care Unit (ICU) Experience which will take place in the Getinge Experience Center, Rastatt on Tuesday 19 September 2017. Over 50 customers from across Europe, Middle East & Africa will be in attendance and have the opportunity to network with scientific experts and medical device industry.
› Verified 6 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
Efforts focused on increasing the use of screening mammography among targeted groups of women should be made a top priority to achieve the largest reduction in late-stage breast cancers, according to the authors of a new study in the October 20 issue of the Journal of the National Cancer Institute.
Cytori Therapeutics, Inc. received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application that protects key therapeutic methods for its breast and soft tissue reconstruction products. This patent will protect Cytori's existing and future products when sold in the U.S.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre.
An intensive structured care program for hypertension management in primary care leads to some improvements in blood pressure control, results from the VIPER-BP trial show.
Getinge announces the next edition of the Intensive Care Unit (ICU) Experience which will take place in the Getinge Experience Center, Rastatt on Tuesday 19 September 2017. Over 50 customers from across Europe, Middle East & Africa will be in attendance and have the opportunity to network with scientific experts and medical device industry.
› Verified 6 days ago
| Entity Name | Orthopedic Assoc Of Lancaster Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609835933 PECOS PAC ID: 8527041987 Enrollment ID: O20040608001128 |
News Archive
Efforts focused on increasing the use of screening mammography among targeted groups of women should be made a top priority to achieve the largest reduction in late-stage breast cancers, according to the authors of a new study in the October 20 issue of the Journal of the National Cancer Institute.
Cytori Therapeutics, Inc. received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application that protects key therapeutic methods for its breast and soft tissue reconstruction products. This patent will protect Cytori's existing and future products when sold in the U.S.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre.
An intensive structured care program for hypertension management in primary care leads to some improvements in blood pressure control, results from the VIPER-BP trial show.
Getinge announces the next edition of the Intensive Care Unit (ICU) Experience which will take place in the Getinge Experience Center, Rastatt on Tuesday 19 September 2017. Over 50 customers from across Europe, Middle East & Africa will be in attendance and have the opportunity to network with scientific experts and medical device industry.
› Verified 6 days ago
| Entity Name | North American Partners In Anesthesia, Pennsylvania , Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639137854 PECOS PAC ID: 7517960834 Enrollment ID: O20060807000040 |
News Archive
Efforts focused on increasing the use of screening mammography among targeted groups of women should be made a top priority to achieve the largest reduction in late-stage breast cancers, according to the authors of a new study in the October 20 issue of the Journal of the National Cancer Institute.
Cytori Therapeutics, Inc. received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application that protects key therapeutic methods for its breast and soft tissue reconstruction products. This patent will protect Cytori's existing and future products when sold in the U.S.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre.
An intensive structured care program for hypertension management in primary care leads to some improvements in blood pressure control, results from the VIPER-BP trial show.
Getinge announces the next edition of the Intensive Care Unit (ICU) Experience which will take place in the Getinge Experience Center, Rastatt on Tuesday 19 September 2017. Over 50 customers from across Europe, Middle East & Africa will be in attendance and have the opportunity to network with scientific experts and medical device industry.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Redmond Hammond, 110 29th Ave N Ste 202, Nashville, TN 37203-1448 Ph: (615) 327-4304 | Jessica Redmond Hammond, 252 S 4th St, Lebanon, PA 17042-6111 Ph: (717) 270-7500 |
News Archive
Efforts focused on increasing the use of screening mammography among targeted groups of women should be made a top priority to achieve the largest reduction in late-stage breast cancers, according to the authors of a new study in the October 20 issue of the Journal of the National Cancer Institute.
Cytori Therapeutics, Inc. received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent application that protects key therapeutic methods for its breast and soft tissue reconstruction products. This patent will protect Cytori's existing and future products when sold in the U.S.
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre.
An intensive structured care program for hypertension management in primary care leads to some improvements in blood pressure control, results from the VIPER-BP trial show.
Getinge announces the next edition of the Intensive Care Unit (ICU) Experience which will take place in the Getinge Experience Center, Rastatt on Tuesday 19 September 2017. Over 50 customers from across Europe, Middle East & Africa will be in attendance and have the opportunity to network with scientific experts and medical device industry.
› Verified 6 days ago
Ms. Lynee K Porter, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 912 Russell Drive, Lebanon, PA 17042 Phone: 717-272-9765 Fax: 717-272-9763 | |
Mrs. Wanda Jean Perez, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 252 S 4th St, Lebanon, PA 17042 Phone: 717-270-7500 Fax: 717-228-1642 | |
Bridget Henderson, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 252 S 4th St, Lebanon, PA 17042 Phone: 717-228-1620 | |
Ashlee Wheeler, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 252 S 4th St, Lebanon, PA 17042 Phone: 717-270-7500 Fax: 717-228-1642 | |
Meredith Anne Dinger, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 252 S 4th St, Lebanon, PA 17042 Phone: 717-270-7500 | |
Kathleen Mattes-longo, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 252 South 4th St, Lebanon, PA 17042 Phone: 717-272-4104 | |
Mrs. Rosette Marie Conkle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 252 S 4th St, Lebanon, PA 17042 Phone: 717-270-7500 Fax: 717-228-1642 |